Ads
related to: Treatment Macular Degenerationwetamd-treatment.com has been visited by 10K+ users in the past month
- Caregiver Virtual Reality
Experience for yourself what life
may be like living with Wet AMD.
- Appointment Tips
Find tips that can help you prepare
for a visit with your doctor.
- Caregiver Virtual Reality
NGM Biopharmaceuticals: Eye Disorder Data Due 2nd Half Of 2022 (NASDAQ:NGM)
Seeking Alpha· 5 days agoThis will be the release of results from the phase 2 CATALINA study using NGM621 for the treatment...
LumiThera Presents US LIGHTSITE III Trial Data Showing Improvement in Vision in Intermediate Dry...
WFMZ Eastern Pennsylvania and Western New Jersey· 4 days agoSEATTLE, June 22, 2022 /PRNewswire/ -- LumiThera Inc., a commercial stage medical device company...
Kinarus Therapeutics to host KOL event on Monday, June 27, to discuss therapies in wet Age-Related ...
Morningstar· 2 days agoKinarus Therapeutics to host KOL event on Monday, June 27, to discuss therapies in wet Age-Related Macular Degeneration and potential advantages of KIN001 ...
Cost of ranibizumab port delivery system for treating nAMD examined
Medical Xpress· 3 days agoFor patients with neovascular age-related macular degeneration (nAMD), ranibizumab with a port...
Vision changes after 40? Here's what you need to know
The Port Lavaca Wave· 1 day agoThe American Academy of Ophthalmology (AAO) suggests everyone see an ophthalmologist for a baseline eye disease screening at age 40, even if there are no apparent problems with their vision.
Apellis (APLS) Expands Deal for Targeted Complement Therapies
Zacks via Yahoo Finance· 3 days agoApellis (APLS) expands its current research and development deal with privately held company,...
Adverum Biotechnologies Obtains EMA’s Priority Medicines Status For Chronic Eye Disorder Candidate -...
Benzinga· 2 days agoThe European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to Adverum Biotechnologies’ ADVM lead drug ADVM-022 for the treatment of wet age-related ...
Aged over 40? Why eye-exams matter
Digital Journal· 6 days agoEye exams are extremely important as people age to prevent blindness from cataracts, glaucoma, retinopathy and macular degeneration. In addition, eye examinations ...
Revenio Group Oyj (OTCMKTS:REVXF) Shares Down 2%
ETF DAILY NEWS· 5 days agoRevenio Group Oyj (OTCMKTS:REVXF – Get Rating) shares dropped 2% during mid-day trading on Monday . The company traded as low as $44.00 and last traded...
EyePoint Pharmaceuticals Announces Election of Tony Adamis, M.D. to Board of Directors
Morningstar· 3 days agoDr. Adamis is a highly accomplished ophthalmology executive with more than 30 years of research and development experience in the biopharmaceutical industry. “Dr. Adamis is a pioneer in the ...
Ads
related to: Treatment Macular Degenerationwetamd-treatment.com has been visited by 10K+ users in the past month